Russell Investments Group, Ltd. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 158 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$127,109
-25.6%
94,858
-0.6%
0.00%
Q2 2023$170,864
-53.5%
95,455
+1.1%
0.00%
-100.0%
Q1 2023$367,137
-26.1%
94,380
-35.4%
0.00%0.0%
Q4 2022$496,943
-29.5%
146,160
+12.9%
0.00%
-50.0%
Q3 2022$705,000
+43.6%
129,415
+18.6%
0.00%
+100.0%
Q2 2022$491,000
+9.8%
109,095
+79.6%
0.00%0.0%
Q1 2022$447,000
+11075.0%
60,746
+8516.5%
0.00%
Q4 2021$4,000
-71.4%
705
-71.9%
0.00%
Q3 2021$14,000
-97.4%
2,510
-95.2%
0.00%
-100.0%
Q2 2021$542,000
+18.9%
52,669
+21.3%
0.00%0.0%
Q1 2021$456,000
-47.2%
43,425
-22.4%
0.00%
-50.0%
Q4 2020$864,000
-3.8%
55,931
-9.2%
0.00%0.0%
Q3 2020$898,000
+65.4%
61,605
+114.2%
0.00%
+100.0%
Q2 2020$543,000
+70.8%
28,758
+73.2%
0.00%0.0%
Q4 2019$318,000
+324.0%
16,600
+277.3%
0.00%
Q2 2018$75,000
+17.2%
4,400
-8.3%
0.00%
Q1 2018$64,000
+36.2%
4,8000.0%0.00%
Q4 2017$47,000
-95.1%
4,800
-93.6%
0.00%
-100.0%
Q1 2017$962,000
+180.5%
74,882
+103.9%
0.00%
+100.0%
Q4 2016$343,00036,7240.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,767,078$80,993,0005.22%
Palo Alto Investors LP 4,663,324$79,230,0003.17%
DOHENY ASSET MANAGEMENT /CA 282,945$4,807,0002.61%
Private Capital Advisors, Inc. 416,900$7,083,0002.22%
Sandia Holdings, LLC 119,739$2,034,0000.91%
Virtus ETF Advisers LLC 44,986$764,0000.68%
Birchview Capital, LP 50,000$850,0000.58%
Schonfeld Strategic Advisors LLC 415,600$7,061,0000.38%
EMERALD ADVISERS, LLC 561,317$9,537,0000.36%
Kazazian Asset Management, LLC 20,672$351,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders